Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/3/2021
Lilly and Innovent Granted Chinese Approval of TYVYT in Combo with G...
6/3/2021
MicuRx's Contezolid Granted Chinese Approval for Drug-Resistant Bacter...
6/3/2021
Bloomberg: China Drugmakers Take Aim at Pharma's Lucrative Cancer Figh...
6/2/2021
Mirati and Zai Lab Enter Into a Collaboration for Adagrasib in Greater...
6/2/2021
WHO Clears Chinese Vaccine Sinovac for Wider Global Use
6/2/2021
CDE Solicits Comments on the Technical Guidelines for Application of B...
6/2/2021
JPO Issues Bidding Documents for the 5th Round of Volume-Based Procure...
6/1/2021
NHSA Reportedly Soliciting Internal Comments on Policy for BMI Drug Pa...
6/1/2021
NMPA Withdraws Approvals of 283 Drug Products Including 12 MNC Product...
5/31/2021
China Issues Interim Guideline for the New Patent Law and Clarifies Pa...
5/31/2021
Financial-related Company News in Brief (May 2021)
5/31/2021
Roots Analysis: Chinese Pharma CMO Market Estimated to Reach $13B in 2...
5/31/2021
Sinovac to Set Up A National Vaccine R&D Center As Part of Related BRI...
5/28/2021
AffaMed Approved for Phase IIb Trial of AM006 in China for Parkinson's...
5/28/2021
CStone's Sugemalimab Trial Met its Primary Endpoint with Upcoming Ch...
5/28/2021
NMPA Issues the Provisions for Drug Inspection (Interim)
5/28/2021
Recent Executive Moves
5/28/2021
NHC: Health Statistics on Chinese Medical Care Providers and Patient V...
5/26/2021
Sinovant and Nabriva Announce Positive Topline Results from Phase 3 T...
5/26/2021
Roche and TransTherato Evaluate Atezolizumab/TT-00420 Combo for GI Ca...
5/25/2021
China and EU Held Pharmaceutical Regulatory Dialogue over Video Confer...
5/24/2021
BeiGene, Novartis Report Promising Topline Results of Tislelizumab ...
5/24/2021
Akeso Submits BLA for Penpulimab mAb in the U.S.
5/21/2021
CARsgen Plans $157M Cancer Cell Therapy Facility in North Carolina
5/21/2021
Recent Executive Moves
5/20/2021
China Briefing: Five Takeaways for Foreign Investors from China's Cens...
5/19/2021
Chinese Hospitals Create Alliance to Enhance Children's Mental Health
5/19/2021
China Joins the International Agency for Research on Cancer (IARC)
5/19/2021
Data Review of Chinese Public Medical Institution Drug Sales in 2020
5/19/2021
68 A Share-listed Chinese Pharma Cos Had Sales Expenditures Over CNY 1...
Page:
93
/
360
Total number of articles:
10791
:
[First]
[<<]
[91]
[92]
[93]
[94]
[95]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit